Strict management of secondary hyperparathyroidism may be necessary to improve prognosis in patients on dialysis who have coronary artery disease requiring percutaneous coronary intervention. High ...

The researchers conducted a systematic review and meta-analysis of 12 case-control studies of patients with NAFLD/NASH and a comparison group without NAFLD/NASH. All studies had data on mean PTH ...

Serum levels of phosphate and parathyroid hormone are lower early in the day and higher late in the day, recently reported data suggest. Phosphate and parathyroid hormone (PTH) levels at the start of ...

Please provide your email address to receive an email when new articles are posted on . A lower parathyroid hormone target treatment method was linked with reduced adjusted hazard of death. The ...

Credit: Getty Images. The phase 3 PaTHway trial included 82 adults with chronic hypoparathyroidism. Positive topline results were announced from a phase 3 trial evaluating the efficacy and safety of ...

Please provide your email address to receive an email when new articles are posted on . At 52 weeks, 81% of adults receiving palopegteriparatide had normalized serum calcium levels without needing ...

PHOENIX — Recombinant human parathyroid hormone (PTH) given subcutaneously improved mineral homeostasis and was well tolerated in a 24-week phase 3 clinical trial of 134 adult patients with ...

Researchers led by Prof. YANG Fan from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences and their collaborators have proposed a new approach to control ...

Trial Designed to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SEP-479 in Healthy Volunteers Data Anticipated in Late 2026 or Early 2027 SOUTH SAN FRANCISCO, Calif., ...